Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Icosapent, also known as Eicosapentaenoic acid (EPA), is a long-chain omega-3 fatty acid that is abundantly available in marine organisms. It is an important polyunsaturated fatty acid that serves as a precursor for the prostaglandin-3 and thromboxane-3 families. EPA has been shown to offer protection against various health conditions, including coronary heart disease, thrombosis, ischemic brain injury, scaly dermatitis, and some inflammatory diseases. It is also used as a biomarker for cardiovascular disease and metabolic disorders.

10417-94-4

Post Buying Request

10417-94-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

10417-94-4 Usage

Uses

Used in Pharmaceutical Industry:
Icosapent is used as an analytical standard for the synthesis and investigation of pharmacological properties of aconitine-derived lipo-alkaloids. It is also used to test pharmacological effects on steatosis in hepatocytes, as an analytical standard in Raman spectra measurements to characterize human breast cancer samples, and in lipid peroxidation assays in mouse embryonic fibroblasts.
Used in Nutritional and Metabolic Disorders:
Icosapent is used as a starting material in the preparation of linearity standards, calibrators, or controls in mass spectrometry-based EPA testing applications. These applications include the assessment of cardiovascular disease risk, detection and quantification of EPA in nutraceuticals and dietary supplements, and evaluation of fatty acid deficiency.
Used in Cardiovascular Health:
Icosapent is used to offer protection against coronary heart disease, thrombosis, and ischemic brain injury. It has been shown to serve as a biomarker for cardiovascular disease, helping in the assessment of disease risk.
Used in Inflammatory Diseases:
Icosapent is used to provide protection against some inflammatory diseases due to its anti-inflammatory properties.
Used in Skin Health:
Icosapent is used to help treat scaly dermatitis, a skin condition characterized by dry, scaly skin.
Brand Name:
Decabid (Lilly) is a brand name for Icosapent.

Biochem/physiol Actions

5-Lipoxygenase inhibitor; reduces thromboxane A2 production.

References

1) Lee et al. (1985), Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function; N. Engl. J. Med., 312 1217 2) Nicholson et al. (2013), The role of marine n-3 fatty acids in improving cardiovascular health: a review; Food Funct., 4 357

Check Digit Verification of cas no

The CAS Registry Mumber 10417-94-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,4,1 and 7 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 10417-94:
(7*1)+(6*0)+(5*4)+(4*1)+(3*7)+(2*9)+(1*4)=74
74 % 10 = 4
So 10417-94-4 is a valid CAS Registry Number.
InChI:InChI=1/C20H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h3-4,6-7,9-10,12-13,15-16H,2,5,8,11,14,17-19H2,1H3,(H,21,22)/b4-3-,7-6-,10-9-,13-12-,16-15-

10417-94-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma

  • (E2011)  cis-5,8,11,14,17-Eicosapentaenoicacid  ≥99%

  • 10417-94-4

  • E2011-10MG

  • 2,290.86CNY

  • Detail
  • Sigma

  • (E2011)  cis-5,8,11,14,17-Eicosapentaenoicacid  ≥99%

  • 10417-94-4

  • E2011-25MG

  • 4,754.88CNY

  • Detail
  • Sigma

  • (E2011)  cis-5,8,11,14,17-Eicosapentaenoicacid  ≥99%

  • 10417-94-4

  • E2011-50MG

  • 6,587.10CNY

  • Detail
  • Sigma

  • (E2011)  cis-5,8,11,14,17-Eicosapentaenoicacid  ≥99%

  • 10417-94-4

  • E2011-100MG

  • 13,139.10CNY

  • Detail
  • Sigma-Aldrich

  • (44864)  cis-5,8,11,14,17-Eicosapentaenoicacid  analytical standard

  • 10417-94-4

  • 44864-100MG

  • 1,296.36CNY

  • Detail
  • Sigma-Aldrich

  • (44864)  cis-5,8,11,14,17-Eicosapentaenoicacid  analytical standard

  • 10417-94-4

  • 44864-500MG

  • 6,282.90CNY

  • Detail

10417-94-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name all-cis-5,8,11,14,17-icosapentaenoic acid

1.2 Other means of identification

Product number -
Other names 5,8,11,14

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:10417-94-4 SDS

10417-94-4Synthetic route

eicosapentaenoic acid ethyl ester
86227-47-6

eicosapentaenoic acid ethyl ester

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

Conditions
ConditionsYield
With ethylenediaminetetraacetic acid; edetate disodium In ethanol; water at 60 - 65℃; for 2h;98%
With immobilized lipase from Candida Antarctica; water In 1,4-dioxane at 55℃; for 3h; Enzymatic reaction;98%
With Candida antarctica lipase; water at 40℃; Hydrolysis;97.6%
(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-icosapentaenoic acid methyl ester
2734-47-6

(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-icosapentaenoic acid methyl ester

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

Conditions
ConditionsYield
With lithium hydroxide In tetrahydrofuran; water93%
With lithium hydroxide In tetrahydrofuran for 15h; Ambient temperature;92%
5,8,11,14,17-eicosapentaynoic acid
5871-07-8

5,8,11,14,17-eicosapentaynoic acid

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

Conditions
ConditionsYield
With hydrogen; Lindlar's catalyst85.5%
eicosapentaenoic acid ethyl ester
86227-47-6

eicosapentaenoic acid ethyl ester

ethanolamine
141-43-5

ethanolamine

A

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

B

(5Z,8Z,11Z,14Z,17Z)-N-(2-hydroxyethyl)eicosa-5,8,11,14,17-pentaenamide

(5Z,8Z,11Z,14Z,17Z)-N-(2-hydroxyethyl)eicosa-5,8,11,14,17-pentaenamide

Conditions
ConditionsYield
With Novozym 435 lipase on resin In acetone at 35℃; for 8h; Green chemistry; Enzymatic reaction;A n/a
B 80%
eicosapentaenoic acid ethyl ester
86227-47-6

eicosapentaenoic acid ethyl ester

serinol
534-03-2

serinol

A

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

B

C23H37NO3

C23H37NO3

Conditions
ConditionsYield
With Novozym 435 lipase on resin In acetone at 35℃; for 8h; Green chemistry; Enzymatic reaction;A n/a
B 80%
2-Amino-1-propanol
6168-72-5

2-Amino-1-propanol

eicosapentaenoic acid ethyl ester
86227-47-6

eicosapentaenoic acid ethyl ester

A

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

B

C23H37NO2

C23H37NO2

Conditions
ConditionsYield
With Novozym 435 lipase on resin In acetone at 35℃; for 8h; Green chemistry; Enzymatic reaction;A n/a
B 78%
3-Dimethylamino-1-propanol
3179-63-3

3-Dimethylamino-1-propanol

eicosapentaenoic acid ethyl ester
86227-47-6

eicosapentaenoic acid ethyl ester

A

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

B

C25H41NO2

C25H41NO2

Conditions
ConditionsYield
With Novozym 435 lipase on resin In acetone at 35℃; for 18h; Green chemistry; Enzymatic reaction;A n/a
B 28%
eicosapentaenoic acid ethyl ester
86227-47-6

eicosapentaenoic acid ethyl ester

serinol
534-03-2

serinol

A

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

B

C23H37NO3
1048012-11-8

C23H37NO3

Conditions
ConditionsYield
With Novozym 435 lipase on resin In acetone at 35℃; for 18h; Green chemistry; Enzymatic reaction;A n/a
B 25%
(2S)-1-O-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-2-O-(6Z,9Z,12Z,15Z-octadecatetranoyl)-3-β-D-galactopyranosyl-sn-glycerol
121245-05-4

(2S)-1-O-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-2-O-(6Z,9Z,12Z,15Z-octadecatetranoyl)-3-β-D-galactopyranosyl-sn-glycerol

A

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

B

(6Z,9Z,12Z,15Z)-Octadeca-6,9,12,15-tetraenoic acid (R)-1-hydroxymethyl-2-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-ethyl ester
144118-12-7

(6Z,9Z,12Z,15Z)-Octadeca-6,9,12,15-tetraenoic acid (R)-1-hydroxymethyl-2-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-ethyl ester

Conditions
ConditionsYield
With Lypase type XIII In 1,4-dioxane; water at 37℃; for 4h; Yield given;
((3Z,6Z,9Z,12Z,15Z)-2-Octadeca-3,6,9,12,15-pentaenyl)-malonic acid

((3Z,6Z,9Z,12Z,15Z)-2-Octadeca-3,6,9,12,15-pentaenyl)-malonic acid

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

Conditions
ConditionsYield
With hydrogenchloride In diethylene glycol dimethyl ether at 120℃; for 1h; Yield given;
2-(1'-oxo-dodeca-5',8',11',14',17'(all Z)-pentaenyl)-1,3,5-trihydroxybenzene
79553-90-5

2-(1'-oxo-dodeca-5',8',11',14',17'(all Z)-pentaenyl)-1,3,5-trihydroxybenzene

A

3,5-dihydroxyphenol
108-73-6

3,5-dihydroxyphenol

B

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

C

(5Z,8Z,11Z,14Z,17Z)-N-hydroxyicosa-5,8,11,14,17-pentaenamide

(5Z,8Z,11Z,14Z,17Z)-N-hydroxyicosa-5,8,11,14,17-pentaenamide

Conditions
ConditionsYield
With sodium hydroxide; hydroxylamine; silica gel 1.) aqueous EtOH, reflux, 2.) heat.; Yield given. Multistep reaction. Yields of byproduct given;
(5Z,8Z,11Z,14Z,17Z)-Icosa-5,8,11,14,17-pentaenoic acid 2-(4-bromo-phenyl)-2-oxo-ethyl ester

(5Z,8Z,11Z,14Z,17Z)-Icosa-5,8,11,14,17-pentaenoic acid 2-(4-bromo-phenyl)-2-oxo-ethyl ester

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

Conditions
ConditionsYield
With potassium hydroxide In methanol; water for 2h; Ambient temperature;
(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenal
137682-11-2

(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenal

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 84 percent / NaBH4 / methanol / 0.33 h / Ambient temperature
2: 74 percent / PPh3*Br2 / acetonitrile
3: 1.) Na / 1.)diglyme 2.) diglyme 140 deg C, 2h
4: 40percent aq NaOH / H2O; ethanol / 4 h / Ambient temperature
5: 1.5 M HCl / bis-(2-methoxy-ethyl) ether / 1 h / 120 °C
View Scheme
all-(Z)-1-bromo-3,6,9,12,15-octadecapentaene
181213-48-9

all-(Z)-1-bromo-3,6,9,12,15-octadecapentaene

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 1.) Na / 1.)diglyme 2.) diglyme 140 deg C, 2h
2: 40percent aq NaOH / H2O; ethanol / 4 h / Ambient temperature
3: 1.5 M HCl / bis-(2-methoxy-ethyl) ether / 1 h / 120 °C
View Scheme
(3Z,6Z,9Z,12Z, 15Z)-octadeca-3,6,9,12,15-pentaen-1-ol
181213-44-5

(3Z,6Z,9Z,12Z, 15Z)-octadeca-3,6,9,12,15-pentaen-1-ol

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 74 percent / PPh3*Br2 / acetonitrile
2: 1.) Na / 1.)diglyme 2.) diglyme 140 deg C, 2h
3: 40percent aq NaOH / H2O; ethanol / 4 h / Ambient temperature
4: 1.5 M HCl / bis-(2-methoxy-ethyl) ether / 1 h / 120 °C
View Scheme
((3Z,6Z,9Z,12Z,15Z)-2-Octadeca-3,6,9,12,15-pentaenyl)-malonic acid diethyl ester
181213-54-7

((3Z,6Z,9Z,12Z,15Z)-2-Octadeca-3,6,9,12,15-pentaenyl)-malonic acid diethyl ester

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 40percent aq NaOH / H2O; ethanol / 4 h / Ambient temperature
2: 1.5 M HCl / bis-(2-methoxy-ethyl) ether / 1 h / 120 °C
View Scheme
1-bromo-pent-2-yne
16400-32-1

1-bromo-pent-2-yne

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1: K2CO3, NaI, CuI / dimethylformamide / 6 h / 20 °C
2: TsOH / methanol / 2 h / 20 °C
3: 85 percent / CBr4, PPh3 / CH2Cl2 / 0.67 h / 0 °C
4: K2CO3, NaI, CuI / dimethylformamide / 6 h / 20 °C
5: TsOH / methanol / 2 h / 20 °C
6: 67 percent / KOH, K2CO3 / H2O; acetone / 1.5 h / 20 °C
7: K2CO3, NaI, CuI / dimethylformamide / 6 h / 20 °C
8: 5percent aq. NaOH / methanol / 4 h / 20 °C
9: 85.5 percent / H2 / Pd/CaCO3/Pb
View Scheme
Multi-step reaction with 9 steps
1: K2CO3, NaI, CuI / dimethylformamide / 6 h / 20 °C
2: TsOH / methanol / 2 h / 20 °C
3: 64.2 percent / KOH, K2CO3 / H2O; acetone / 1.5 h / 20 °C
4: K2CO3, NaI, CuI / dimethylformamide / 6 h / 20 °C
5: TsOH / methanol / 2 h / 20 °C
6: 67 percent / KOH, K2CO3 / H2O; acetone / 1.5 h / 20 °C
7: K2CO3, NaI, CuI / dimethylformamide / 6 h / 20 °C
8: 5percent aq. NaOH / methanol / 4 h / 20 °C
9: 85.5 percent / H2 / Pd/CaCO3/Pb
View Scheme
pent-2-yn-1-ol
6261-22-9

pent-2-yn-1-ol

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

Conditions
ConditionsYield
Multi-step reaction with 10 steps
1: 78 percent / CBr4, PPh3 / CH2Cl2 / 0.67 h / 0 °C
2: K2CO3, NaI, CuI / dimethylformamide / 6 h / 20 °C
3: TsOH / methanol / 2 h / 20 °C
4: 85 percent / CBr4, PPh3 / CH2Cl2 / 0.67 h / 0 °C
5: K2CO3, NaI, CuI / dimethylformamide / 6 h / 20 °C
6: TsOH / methanol / 2 h / 20 °C
7: 67 percent / KOH, K2CO3 / H2O; acetone / 1.5 h / 20 °C
8: K2CO3, NaI, CuI / dimethylformamide / 6 h / 20 °C
9: 5percent aq. NaOH / methanol / 4 h / 20 °C
10: 85.5 percent / H2 / Pd/CaCO3/Pb
View Scheme
Multi-step reaction with 10 steps
1: 78 percent / CBr4, PPh3 / CH2Cl2 / 0.67 h / 0 °C
2: K2CO3, NaI, CuI / dimethylformamide / 6 h / 20 °C
3: TsOH / methanol / 2 h / 20 °C
4: 64.2 percent / KOH, K2CO3 / H2O; acetone / 1.5 h / 20 °C
5: K2CO3, NaI, CuI / dimethylformamide / 6 h / 20 °C
6: TsOH / methanol / 2 h / 20 °C
7: 67 percent / KOH, K2CO3 / H2O; acetone / 1.5 h / 20 °C
8: K2CO3, NaI, CuI / dimethylformamide / 6 h / 20 °C
9: 5percent aq. NaOH / methanol / 4 h / 20 °C
10: 85.5 percent / H2 / Pd/CaCO3/Pb
View Scheme
all cis-5,8,11,14,17-eicosapentaenoic acid

all cis-5,8,11,14,17-eicosapentaenoic acid

17,18-Epoxyeicosatetraenoic acid
1283063-45-5

17,18-Epoxyeicosatetraenoic acid

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

docosahexaenoic acid
6217-54-5

docosahexaenoic acid

magnesium bis(lysinate) trihydrate

magnesium bis(lysinate) trihydrate

magnesium Bis-Lysinate Mono-EPA Mono-DHA dihydrate

magnesium Bis-Lysinate Mono-EPA Mono-DHA dihydrate

Conditions
ConditionsYield
With Tocopherol In methanol; ethyl acetate at 50℃; for 0.333333h; Inert atmosphere;100%
all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

magnesium bis-lysinate monohydrate

magnesium bis-lysinate monohydrate

magnesium bis-lysinate bis-EPA dihydrate

magnesium bis-lysinate bis-EPA dihydrate

Conditions
ConditionsYield
With Tocopherol In methanol; ethyl acetate at 50℃; for 0.333333h; Inert atmosphere;100%
all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

magnesium bis-lysinate monohydrate

magnesium bis-lysinate monohydrate

magnesium bis-lysinate mono-EPA

magnesium bis-lysinate mono-EPA

Conditions
ConditionsYield
With Tocopherol In methanol; ethyl acetate at 50℃; for 0.333333h; Inert atmosphere;100%
all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

L-leucyl-L-leucine
3303-31-9

L-leucyl-L-leucine

dimethylbiguanide
657-24-9

dimethylbiguanide

C12H24N2O3*C4H11N5*C20H30O2

C12H24N2O3*C4H11N5*C20H30O2

Conditions
ConditionsYield
In methanol at 20℃; for 5h;100%
all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

pyridoxamine
85-87-0

pyridoxamine

(3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl)methanaminium (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

(3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl)methanaminium (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 2h;100%
all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

(S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl) propan-1-aminium (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

(S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl) propan-1-aminium (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

Conditions
ConditionsYield
In tetrahydrofuran for 2h;100%
all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

L-Aspartic acid
56-84-8

L-Aspartic acid

dimethylbiguanide
657-24-9

dimethylbiguanide

bis[{[(dimethylamino)(imino)methyl]amino}(imino)methanaminium]-(5Z,8Z,11Z,14Z,17Z)-eicosa-5,8,11,14,17-pentaenoate-(3S)-3-ammonio-3-carboxypropanoate

bis[{[(dimethylamino)(imino)methyl]amino}(imino)methanaminium]-(5Z,8Z,11Z,14Z,17Z)-eicosa-5,8,11,14,17-pentaenoate-(3S)-3-ammonio-3-carboxypropanoate

Conditions
ConditionsYield
In methanol at 60℃; for 1.5h;99%
all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

1,2-di-O-palmitoyl-sn-glycerol
6076-30-8

1,2-di-O-palmitoyl-sn-glycerol

1-((5Z,8Z,11Z,14Z,17Z)-eicosa-5,8,11,14,17-pentaenoyl)-2,3-dihexadecanoyl-sn-glycerol

1-((5Z,8Z,11Z,14Z,17Z)-eicosa-5,8,11,14,17-pentaenoyl)-2,3-dihexadecanoyl-sn-glycerol

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; Steglich Esterification;99%
methanol
67-56-1

methanol

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-icosapentaenoic acid methyl ester
2734-47-6

(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-icosapentaenoic acid methyl ester

Conditions
ConditionsYield
Stage #1: all cis-5,8,11,14,17-eicosapentaenoic acid With oxalyl dichloride In benzene at 20℃; for 2h;
Stage #2: methanol at 0 - 20℃; for 2h;
98%
With acetyl chloride at 20℃; for 1.5h; Inert atmosphere;
With boron trifluoride diethyl etherate In benzene at 100℃; for 1h;
all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

6-[(3Z,6Z,9Z,12Z)-1-iodopentadeca-3,6,9,12-tetraen-1-yl]-tetrahydro-2H-pyran-2-one
234087-56-0

6-[(3Z,6Z,9Z,12Z)-1-iodopentadeca-3,6,9,12-tetraen-1-yl]-tetrahydro-2H-pyran-2-one

Conditions
ConditionsYield
With 2,6-dimethylpyridine; iodine In dichloromethane at 0℃; for 15h; Inert atmosphere; Cooling with ice;97%
With iodine; potassium hydrogencarbonate; potassium iodide In tetrahydrofuran; water for 48h; Ambient temperature;95%
With 2,4,6-trimethyl-pyridine; iodine In acetonitrile at 20℃;88%
all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

calcium bis(lysinate) monohydrate

calcium bis(lysinate) monohydrate

calcium bis-lysinate mono-EPA

calcium bis-lysinate mono-EPA

Conditions
ConditionsYield
In methanol for 0.25h;97%
all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

C10H19IO2

C10H19IO2

C30H48O4

C30H48O4

Conditions
ConditionsYield
Stage #1: all cis-5,8,11,14,17-eicosapentaenoic acid With triethylamine; sodium iodide In ethyl acetate at 20℃; for 0.0333333h; Inert atmosphere;
Stage #2: C10H19IO2 In ethyl acetate at 50℃;
97%
With triethylamine; sodium iodide In ethyl acetate for 16h; Inert atmosphere; Reflux;97%
3-METHOXYBENZYLAMINE
5071-96-5

3-METHOXYBENZYLAMINE

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

N-(3-methoxybenzyl)icosa-5Z,8Z,11Z,14Z,17Z-pentaenamide

N-(3-methoxybenzyl)icosa-5Z,8Z,11Z,14Z,17Z-pentaenamide

Conditions
ConditionsYield
Stage #1: all cis-5,8,11,14,17-eicosapentaenoic acid With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 0.25h; Inert atmosphere;
Stage #2: 3-METHOXYBENZYLAMINE In dichloromethane Inert atmosphere;
97%
all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

pilocarpine hydrochloride
54-71-7

pilocarpine hydrochloride

5-(((3R,4S)-4-ethyl-5-oxotetrahydrofuran-3-yl)methyl)-1-methyl-1H-imidazol-1-ium (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

5-(((3R,4S)-4-ethyl-5-oxotetrahydrofuran-3-yl)methyl)-1-methyl-1H-imidazol-1-ium (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

Conditions
ConditionsYield
Stage #1: pilocarpine hydrochloride With sodium hydrogencarbonate In methanol for 0.0833333h;
Stage #2: all cis-5,8,11,14,17-eicosapentaenoic acid In methanol at 20℃; for 16h;
96.8%
all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

(5Z,8Z,11Z,14Z,17Z)-N-hydroxyicosa-5,8,11,14,17-pentaenamide

(5Z,8Z,11Z,14Z,17Z)-N-hydroxyicosa-5,8,11,14,17-pentaenamide

Conditions
ConditionsYield
Stage #1: all cis-5,8,11,14,17-eicosapentaenoic acid With 1,1'-carbonyldiimidazole In dichloromethane at 20℃; for 0.5h;
Stage #2: With hydroxylamine In dichloromethane for 12h;
96%
all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-icosapentaenoic acid

(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-icosapentaenoic acid

Conditions
ConditionsYield
Stage #1: all cis-5,8,11,14,17-eicosapentaenoic acid With 1,1'-carbonyldiimidazole In dichloromethane at 20℃; for 0.5h;
Stage #2: With 1,1,1,3,3,3-hexamethyl-disilazane In dichloromethane for 12h;
96%
pyrrolidine
123-75-1

pyrrolidine

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

(5Z,8Z,11Z,14Z,17Z)-1-(pyrrolidin-1-yl)icosa-5,8,11,14,17-pentaen-1-one

(5Z,8Z,11Z,14Z,17Z)-1-(pyrrolidin-1-yl)icosa-5,8,11,14,17-pentaen-1-one

Conditions
ConditionsYield
Stage #1: all cis-5,8,11,14,17-eicosapentaenoic acid With 1,1'-carbonyldiimidazole In dichloromethane at 20℃; for 0.5h;
Stage #2: pyrrolidine In dichloromethane for 12h;
96%
piperidine
110-89-4

piperidine

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

(5Z,8Z,11Z,14Z,17Z)-1-(piperidin-1-yl)icosa-5,8,11,14,17-pentaen-1-one

(5Z,8Z,11Z,14Z,17Z)-1-(piperidin-1-yl)icosa-5,8,11,14,17-pentaen-1-one

Conditions
ConditionsYield
Stage #1: all cis-5,8,11,14,17-eicosapentaenoic acid With 1,1'-carbonyldiimidazole In dichloromethane at 20℃; for 0.5h;
Stage #2: piperidine In dichloromethane for 12h;
96%
morpholine
110-91-8

morpholine

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

(5Z,8Z,11Z,14Z,17Z)-1-morpholinoicosa-5,8,11,14,17-pentaen-1-one

(5Z,8Z,11Z,14Z,17Z)-1-morpholinoicosa-5,8,11,14,17-pentaen-1-one

Conditions
ConditionsYield
Stage #1: all cis-5,8,11,14,17-eicosapentaenoic acid With 1,1'-carbonyldiimidazole In dichloromethane at 20℃; for 0.5h;
Stage #2: morpholine In dichloromethane for 12h;
96%
1-methyl-piperazine
109-01-3

1-methyl-piperazine

all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

(5Z,8Z,11Z,14Z,17Z)-1-(4-methylpiperazin-1-yl)icosa-5,8,11,14,17-pentaen-1-one

(5Z,8Z,11Z,14Z,17Z)-1-(4-methylpiperazin-1-yl)icosa-5,8,11,14,17-pentaen-1-one

Conditions
ConditionsYield
Stage #1: all cis-5,8,11,14,17-eicosapentaenoic acid With 1,1'-carbonyldiimidazole In dichloromethane at 20℃; for 0.5h;
Stage #2: 1-methyl-piperazine In dichloromethane for 12h;
96%
all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

benzylamine
100-46-9

benzylamine

(5Z,8Z,11Z,14Z,17Z)-N-benzylicosa-5,8,11,14,17-pentaenamide

(5Z,8Z,11Z,14Z,17Z)-N-benzylicosa-5,8,11,14,17-pentaenamide

Conditions
ConditionsYield
Stage #1: all cis-5,8,11,14,17-eicosapentaenoic acid With 1,1'-carbonyldiimidazole In dichloromethane at 20℃; for 0.5h;
Stage #2: benzylamine In dichloromethane for 12h;
96%
Stage #1: all cis-5,8,11,14,17-eicosapentaenoic acid With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane for 0.25h; Inert atmosphere;
Stage #2: benzylamine In dichloromethane Inert atmosphere;
90%
all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

rac-methylbenzylamine
618-36-0

rac-methylbenzylamine

(5Z,8Z,11Z,14Z,17Z)-N-(1-phenylethyl)icosa-5,8,11,14,17-pentaenamide

(5Z,8Z,11Z,14Z,17Z)-N-(1-phenylethyl)icosa-5,8,11,14,17-pentaenamide

Conditions
ConditionsYield
Stage #1: all cis-5,8,11,14,17-eicosapentaenoic acid With 1,1'-carbonyldiimidazole In dichloromethane at 20℃; for 0.5h;
Stage #2: rac-methylbenzylamine In dichloromethane for 12h;
96%
all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

(S)-1-phenyl-ethylamine
2627-86-3

(S)-1-phenyl-ethylamine

(5Z,8Z,11Z,14Z,17Z)-N-((S)-1-phenylethyl)icosa-5,8,11,14,17-pentaenamide

(5Z,8Z,11Z,14Z,17Z)-N-((S)-1-phenylethyl)icosa-5,8,11,14,17-pentaenamide

Conditions
ConditionsYield
Stage #1: all cis-5,8,11,14,17-eicosapentaenoic acid With 1,1'-carbonyldiimidazole In dichloromethane at 20℃; for 0.5h;
Stage #2: (S)-1-phenyl-ethylamine In dichloromethane for 12h;
96%
all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

ethanolamine
141-43-5

ethanolamine

(5Z,8Z,11Z,14Z,17Z)-N-(2-hydroxyethyl)eicosa-5,8,11,14,17-pentaenamide

(5Z,8Z,11Z,14Z,17Z)-N-(2-hydroxyethyl)eicosa-5,8,11,14,17-pentaenamide

Conditions
ConditionsYield
Stage #1: all cis-5,8,11,14,17-eicosapentaenoic acid With 1,1'-carbonyldiimidazole In dichloromethane at 20℃; for 0.5h;
Stage #2: ethanolamine In dichloromethane for 12h;
95%
Stage #1: all cis-5,8,11,14,17-eicosapentaenoic acid With 1-[(1-(cyano-2-ethoxy-2-oxoethylidenaminooxy)dimethylamino-morpholino)]-uronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In dichloromethane; acetonitrile at 20℃; for 0.166667h; Inert atmosphere;
Stage #2: ethanolamine In dichloromethane; acetonitrile at 20℃; Inert atmosphere;
85%
With Novozym 435, consisting of immobilized Candida antarctica lipase B In hexane at 40℃; for 15h; Enzymatic reaction;83%
all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

N-ε-tert-butoxycarbonyl-L-lysine methyl ester hydrochloride
2389-48-2

N-ε-tert-butoxycarbonyl-L-lysine methyl ester hydrochloride

(S)-methyl 6-(tert-butoxycarbonyl)-2-((5Z,8Z,11Z,14Z,17Z)-eicosa-5,8,11,14,17-pentaenamido)hexanoate
1269181-97-6

(S)-methyl 6-(tert-butoxycarbonyl)-2-((5Z,8Z,11Z,14Z,17Z)-eicosa-5,8,11,14,17-pentaenamido)hexanoate

Conditions
ConditionsYield
With 2-(7-aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; for 2h;95%
With N-ethyl-N,N-diisopropylamine; HATU In acetonitrile at 20℃; for 2h;
all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

(S)-methyl 2-amino-6-(tert-butoxycarbonylamino)hexanoate
3017-32-1

(S)-methyl 2-amino-6-(tert-butoxycarbonylamino)hexanoate

(S)-methyl 6-(tert-butoxycarbonyl)-2-((5Z,8Z,11Z,14Z,17Z)-eicosa-5,8,11,14,17-pentaenamido)hexanoate
1269181-97-6

(S)-methyl 6-(tert-butoxycarbonyl)-2-((5Z,8Z,11Z,14Z,17Z)-eicosa-5,8,11,14,17-pentaenamido)hexanoate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; HATU In acetonitrile at 20℃; for 2h;95%
all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

1,3-distearoylglycerol
504-40-5

1,3-distearoylglycerol

1,3-stearoyl-2-eicosapentaenoyl-glycerol

1,3-stearoyl-2-eicosapentaenoyl-glycerol

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; for 24h;94%
With dmap; dicyclohexyl-carbodiimide
all cis-5,8,11,14,17-eicosapentaenoic acid
10417-94-4

all cis-5,8,11,14,17-eicosapentaenoic acid

1,2-distearoyl-sn-glycerol
1429-59-0, 10567-21-2

1,2-distearoyl-sn-glycerol

3-((5Z,8Z,11Z,14Z,17Z)-eicosa-5,8,11,14,17-pentaenoyl)-1,2-dioctadecanoyl-sn-glycerol

3-((5Z,8Z,11Z,14Z,17Z)-eicosa-5,8,11,14,17-pentaenoyl)-1,2-dioctadecanoyl-sn-glycerol

Conditions
ConditionsYield
With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In dichloromethane at 20℃; Steglich Esterification;94%

10417-94-4Related news

DHA and EPA (cas 10417-94-4) nanoemulsions prEPA (cas 10417-94-4)red by the low-energy emulsification method: Process factors influencing droplet size and physicochemical stability08/01/2019

To extend the application of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) in liquid food, and to improve the physicochemical stability, we prepared stable DHA and EPA nanoemulsions, which can be used for large scale production. The Emulsion Phase Inversion (EPI) method was used to ...detailed

10417-94-4Relevant articles and documents

Apoptosis-inducing galactolipids from a cultured marine diatom, Phaeodactylum tricornutum

Andrianasolo, Eric H.,Haramaty, Liti,Vardi, Assaf,White, Eileen,Lutz, Richard,Falkowski, Paul

, p. 1197 - 1201 (2008)

Two monogalactosyl diacylglycerols, 1 and 2, were isolated from the marine diatom Phaeodactylum tricornutum, using the patented ApopScreen cell-based screen for apoptosis-inducing, potential anticancer compounds. The molecular structures of the galactolipids were determined using a combination of NMR, mass spectrometry, and chemical degradation. The bioactivities were confirmed using a specific apoptosis induction assay based on genetically engineered mammalian cell lines with differential, defined capacities for apoptosis. The galactolipids induce apoptosis in micromolar concentrations. This is the first report of apoptosis induction by galactolipids.

Enzymatic synthesis of 1,3-dicapryloyl-2-eicosapentaenoylglycerol

Irimescu, Roxana,Yasui, Mamoru,Iwasaki, Yugo,Shimidzu, Nobuyoshi,Yamane, Tsuneo

, p. 501 - 506 (2000)

1,3-Dicapryloyl-2-eicosapentaenoylglycerol (CEC) was synthesized by interesterification of trieicosapentaenoylglycerol (EEE) with ethyl caprylate (EtC) catalyzed by LipozymeTM. After some of the reaction conditions were optimized, the maximal molar content of CEC in the glycerides of the reaction mixture was 91%. Among the parameters studied in the optimization, the critical ones were: (i) the water content, which influenced the conversion of EEE to CEC and 1-capryloyl-2-eicosapentaenoylglycerol (CEOH), and (ii) the timing of water removal under reduced pressure for the reesterification of CEOH to form CEC. The complete synthesis of CEC from ethyl eicosapentaenoate (EtE) was performed in three steps: (i) hydrolysis of EtE to free eicosapentaenoic acid (EPA), (ii) esterification of glycerol with EPA to form EEE, and (iii) interesterification of EEE with EtC under the optimized conditions. The first two steps were catalyzed by NovozymTM and the third by LipozymeTM. The total yield over all the steps was 88%, and no purification of the intermediates was necessary. The regioisomeric purity of the product was 100% by silver-ion high-pressure liquid chromatography.

A simple preparation of 17(R)-hydroxyeicosatetraenoic and eicosapentaenoic acids from the eicosanoylphloroglucinols, components of the brown alga, Zonaria diesingiana

Munakata, Tatsuo,Ooi, Takashi,Kusumi, Takenori

, p. 249 - 250 (1997)

The alkaline treatment of 17(R)-hydroxyeicosatetraenoylphloroglucinol and eicosapentaenoylphloroglucinol, which are the major components of the methanol extract of the brown alga, Zonaria diesingiana (Dictyota) afforded 17(R)-hydroxyeicosatetraenoic and eicosapentaenoic acids, respectively, in good yields. The conformation of methyl ester of the 17(R)-hydroxy acid in a solution was studied by using 2NMA, a chiral anisotropic reagent.

Antioxidative Properties and Chemical Changes of Quercetin in Fish Oil: Quercetin Reacts with Free Fatty Acids to Form Its Ester Derivatives

Liu, Shaojun,Zhu, Yamin,Liu, Ning,Fan, Daming,Wang, Mingfu,Zhao, Yueliang

, p. 1057 - 1067 (2021)

In this research, we studied the antioxidative properties and chemical changes of quercetin in fish oil during accelerated storage at 60 °C for 5 days. Gas chromatography (GC) analysis showed that quercetin inhibited aldehyde formation and unsaturated fatty acid oxidation in fish oil significantly; however, the inhibitory effects decreased gradually with prolonged heating time. Moreover, quercetin was consumed with increasing heating time. Some new phenolic derivatives were discovered in the fish oil with quercetin, with their structures fully elucidated by LC-MS/MS and comparison with newly synthesized ones (characterized by MS and NMR spectroscopy). Based on their chemical structures, we proposed that quercetin reacted with EPA and DHA to form the corresponding quercetin fatty acid esters in fish oil. In addition, the newly formed quercetin-3-O-eicosapentaenoate and quercetin-3-O-docosahexaenoate showed weaker DPPH and ABTS radical cation scavenging activity but much improved lipophilicity, higher cell membrane affinity, and hence enhanced cellular antioxidant activity compared with the parent quercetin. Overall, quercetin could be used as a safe dietary polyphenol to inhibit lipid oxidation. The newly formed quercetin-polyunsaturated fatty acid esters may render improved bioactivity to humans, which needs further investigation.

Chemoenzymatic synthesis of symmetrically structured triacylglycerols possessing short-chain fatty acids

Magnusson, Carlos D.,Haraldsson, Gudmundur G.

, p. 2728 - 2731 (2010)

Synthesis of symmetrically structured triacylglycerols possessing bioactive n-3 polyunsaturated fatty acids (eicosapentaenoic acid or docosahexaenoic acid) at the 2-position and a short-chain fatty acid (C2, C4, C6) located at the end-positions by a highly efficient two-step chemoenzymatic process is described. Full regiocontrol devoid of any acyl-migration side reactions was obtained in both a lipase promoted step to introduce the short-chain fatty acids exclusively into the primary alcohol positions of glycerol using activated vinyl esters at low temperature and a subsequent coupling reaction involving free EPA and DHA using EDAC as a coupling agent.

Chemoenzymatic synthesis of structured triacylglycerols containing eicosapentaenoic and docosahexaenoic acids

Haraldsson, Gudmundur G.,Halldorsson, Arnar,Kulas, Elin

, p. 1139 - 1145 (2000)

There are indications in the recent literature that the location of polyunsaturated fatty acids, such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), in triacylglycerols (TAG) may influence their oxidative stability. To address that question, two types of structured lipids were designed and synthesized: firstly, a TAG molecule possessing pure EPA or DHA at the mid-position with stearic acid at the outer positions; and secondly, a TAG molecule possessing pure EPA or DHA located at one of the outer positions with stearic acid at the mid-position and the remaining end position. The former adduct was synthesized in two steps by a chemoenzymatic approach. In the first step 1,3-distearoylglycerol was afforded in good yield (74%) by esterifying glycerol with two equivalents of stearic acid in ether in the presence of silica gel using LipozymeTM as a biocatalyst. This was followed by a subsequent chemical esterification with pure EPA or DHA using 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide as a coupling agent in the presence of 4-dimethylaminopyridine in dichloro-methane in excellent yields (94 and 91%, respectively). The latter adduct was synthesized in two enzymatic steps. In the first step tristearoylglycerol was prepared in very high yield (88%) by esterifying glycerol with a stoichiometric amount of stearic acid under vacuum at 70-75 °C using an immobilized Candida antarctica lipase without a solvent. That adduct was subsequently treated in an acidolysis reaction with two equivalents of EPA or DHA without solvent at 70-75 °C or in toluene at 40 °C in the presence of Lipozyme to afford the desired product in moderate yields (44 and 29%, respectively).

An allelopathic polyunsaturated fatty acid from red algae

Suzuki, Minoru,Wakana, Isamu,Denboh, Takashi,Tatewaki, Masakazu

, p. 63 - 65 (1996)

An allelopathic substance, which displays growth-inhibitory activity and spore-settlement suppressive activity, was isolated from some red algae and identified as (5Z,8Z, 11Z, 14Z, 17Z)-eicosapentaenoic acid on the basis of spectroscopic and chemical evidence.

Chemoenzymatic synthesis of a focused library of enantiopure structured 1-O-alkyl-2,3-diacyl-sn-glycerol type ether lipids

Magnusson, Carlos D.,Gudmundsdottir, Anna V.,Haraldsson, Gudmundur G.

, p. 1821 - 1836 (2011)

A highly efficient two-step chemoenzymatic synthesis of enantiopure structured ether lipids of the 1-O-alkyl-2,3-diacyl-sn-glycerol type has been developed. Chimyl, batyl and selachyl alcohols possessing pure saturated fatty acid (SFA) attached to the sn-3 position and pure EPA and DHA attached to the sn-2 position were obtained under full regiocontrol. This was offered by mild conditions and a highly efficient lipase that operated at room temperature. High-resolution 1H NMR spectroscopy was used to monitor the progress of the reactions and to evaluate the full regiocontrol of the reactions involved by keeping track of all prospective adducts involved in these reactions. This was extended to preparation of a focused library of eight monoacyl intermediate adducts for all even-numbered SFA ranging from C2-C16 and the corresponding EPA and DHA structured diacyl glycerol ethers (DAGE) products for chimyl, batyl and selachyl alcohols, the total of 72 compounds.

Lyophilized extracts from vegetable flours as valuable alternatives to purified oxygenases for the synthesis of oxylipins

Sanfilippo, Claudia,Paterna, Angela,Biondi, Daniela M.,Patti, Angela

, (2019/10/05)

In this work, the whole aqueous extracts of soybean flour and oat flour have been used as valuable alternatives to purified oxygenase enzymes for the preparation of oxylipins derived from (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoic acid (EPA). The lipoxygenase activity in the aqueous extracts of soybean (Glycine max. L.) flour was monitored with linoleic acid as substrate and compared with the commercially available purified enzyme (LOX-1). Oat flour extracts (Avena sativa L.) were evaluated for their peroxygenase activity by comparing different enzyme preparations in the epoxidation of methyl oleate. It was found that lyophilization of the aqueous extracts from these vegetable flours offers advantages in terms of enzyme stability, reproducibility and applicability to preparative organic synthesis. The lyophilized enzyme preparations were tested for the oxyfunctionalization of EPA and the formed products were isolated in satisfactory yields. In the presence of lyophilized extract from soybean, EPA gave 15S-hydroxy-(5Z,8Z,11Z,13E,17Z)-eicosapentaenoic acid in enantiopure form as exclusive product. Peroxygenase from oat flour was less selective and catalyzed the formation of different epoxides of EPA. However, the biocatalyzed epoxidation of EPA under controlled conditions allowed to obtain optically active (17R,18S)-epoxy-(5Z,8Z,11Z,14Z)-eicosatetraenoic acid (65% ee) as the main monoepoxide, among the five possible ones.

COMPOSITIONS AND METHODS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME

-

Paragraph 00130; 00132, (2018/03/06)

The disclosures herein provide compounds of formula I, formula II, formula III, formula IV, formula V, formula VI, formula VII, formula VIII, formula IX, formula X, formula XI, formula XII, formula XIII, formula XIV and formula XV or its pharmaceutical acceptable salts, as well as polymorphs, enantiomers, stereoisomers, solvates, and hydrates thereof. These salts may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for oral administration, suppository, transdermal, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection. Such compositions may be used to treatment of irritable bowel syndrome (IBS), inflammatory bowel diseases or its associated complications.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 10417-94-4